Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VANI Vivani Medical, Inc.

Market Closed 12-12 16:00:00 EST

1.35

-0.04

-2.88%

盘后1.35

+0.000.00%

17:29 EST

High1.44	Low1.34	Vol191.99K
Open1.40	D1 Closing1.39	Amplitude7.19%
Mkt Cap98.49M	Tradable Cap48.70M	Total Shares72.95M
T/O263.19K	T/O Rate0.53%	Tradable Shares36.07M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"VANI","market":"US","secType":"STK","nameCN":"Vivani Medical, Inc.","latestPrice":1.35,"timestamp":1765573200000,"preClose":1.39,"halted":0,"volume":191990,"hourTrading":{"tag":"盘后","latestPrice":1.35,"preClose":1.35,"latestTime":"17:29 EST","volume":145,"amount":198.1296,"timestamp":1765578597443},"delay":0,"floatShares":36073112,"shares":72952235,"eps":-0.441796,"marketStatus":"Market Closed","change":-0.04,"latestTime":"12-12 16:00:00 EST","open":1.4,"high":1.44,"low":1.34,"amount":263190.470649,"amplitude":0.071942,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.441796,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1416373200000,"exchange":"NASDAQ","adjPreClose":1.39,"preHourTrading":{"tag":"盘前","latestPrice":1.3919,"preClose":1.39,"latestTime":"09:15 EST","volume":4025,"amount":5331.45543,"timestamp":1765548956243},"postHourTrading":{"tag":"盘后","latestPrice":1.35,"preClose":1.35,"latestTime":"17:29 EST","volume":145,"amount":198.1296,"timestamp":1765578597443},"volumeRatio":0.9920292496474435,"impliedVol":1.4716,"impliedVolPercentile":0.772},"requestUrl":"/m/hq/s/VANI/wiki","defaultTab":"wiki","newsList":[{"id":"2586418184","title":"Vivani Medical Inc. unveils presentation on subdermal semaglutide implant for chronic weight management","url":"https://stock-news.laohu8.com/highlight/detail?id=2586418184","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586418184?lang=en_us&edition=fundamental","pubTime":"2025-11-25 05:45","pubTimestamp":1764020727,"startTime":"0","endTime":"0","summary":"Vivani Medical Inc. has published a presentation outlining its progress and strategy in the obesity and chronic disease treatment market. The company is developing NPM-139, a miniature, subdermal semaglutide implant designed for chronic weight management in obese and overweight individuals. Unlike currently approved GLP-1 therapies, which are available only as injectables or orals, Vivani's NanoPortal technology enables dosing every 6 to 12 months via a subdermal implant. The company reports that its LIBERATE-1 first-in-human study achieved its primary objectives, demonstrating positive safety, tolerability, and device performance. Vivani projects that its cash runway will extend through key milestones and into 2027, with the NPM-139 clinical program set to begin in the first half of 2026. The presentation also notes the growing GLP-1 market, which is expected to reach $139 billion by 2030. You can access the full presentation through the link below.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL6yrhcx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2584226479","title":"Vivani Medical Q3 Net Income USD -6.53 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584226479","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584226479?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:37","pubTimestamp":1763573867,"startTime":"0","endTime":"0","summary":"Nov 13 (Reuters) - Vivani Medical Q3 operating expenses USD 6.725 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-NOV-202512:37:19.477 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD7dW2WL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2584629172","title":"Director and 10% Owner Gregg Williams Reports Acquisition of Vivani Medical Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584629172","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584629172?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:00","pubTimestamp":1763388058,"startTime":"0","endTime":"0","summary":"Gregg Williams, a Director and 10% Owner of Vivani Medical Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL9MfTP7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner Gregg Williams Reports Acquisition of Vivani Medical Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2583610560","title":"Vivani Medical reports wider Q3 net loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2583610560","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583610560?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:52","pubTimestamp":1763038372,"startTime":"0","endTime":"0","summary":"Vivani Medical reports wider Q3 net lossOverviewVivani reports Q3 net loss widening to $6.5 mln, with increased operating expensesVivani secures $25.7 mln in cash and commitments for development proje","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP0II:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CRGT","VANI"],"gpt_icon":0},{"id":"2583349560","title":"Vivani Medical Q3 EPS $(0.11), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2583349560","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583349560?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:47","pubTimestamp":1763038043,"startTime":"0","endTime":"0","summary":"Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is unchanged from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48830953/vivani-medical-q3-eps-0-11-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","SQQQ","TSYW.SI","QID","BK4082","PSQ","USAW.SI","USJW.SI","VANI","NQmain","NVIW.SI","TQQQ","MNQmain","QLD"],"gpt_icon":0},{"id":"2583560384","title":"BRIEF-Vivani Medical Q3 Net Income USD -6.53 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583560384","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583560384?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:45","pubTimestamp":1763037946,"startTime":"0","endTime":"0","summary":"BRIEF-Vivani Medical Q3 Net Income USD -6.53 Million\n\n\nNov 13 (Reuters) - Vivani Medical Q3 operating expenses USD 6.725 million.\n\nQ3 income from operations USD -6.725 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX809037:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2583856031","title":"Vivani Medical Q3 Operating Expenses USD 6.725 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583856031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583856031?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:45","pubTimestamp":1763037901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX809037:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2583560396","title":"Vivani Medical : Anticipates Initiating Clinical Development of Semaglutide Implant, Npm-139 in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2583560396","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583560396?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:45","pubTimestamp":1763037901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX809037:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2583560313","title":"Vivani Medical Q3 Income From Operations USD -6.725 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583560313","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583560313?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:45","pubTimestamp":1763037901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX809037:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2583560395","title":"Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583560395","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583560395?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:45","pubTimestamp":1763037900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUABHSRYG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2582612802","title":"Vivani Medical Inc. unveils obesity market strategy with new GLP-1 implant technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2582612802","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582612802?lang=en_us&edition=fundamental","pubTime":"2025-11-11 04:07","pubTimestamp":1762805253,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL87JXtr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2581703882","title":"Vivani Medical Inc  expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581703882","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581703882?lang=en_us&edition=fundamental","pubTime":"2025-11-08 00:03","pubTimestamp":1762531384,"startTime":"0","endTime":"0","summary":"Vivani Medical Inc  expected to post a loss of11cents a share - Earnings Preview Vivani Medical Inc VANI.OQ VANI.O is expected to  show no change in quarterly revenue when it reports  results on Novem","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL8N3WJ29V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2578952152","title":"Director and 10% Owner Gregg Williams Reports Acquisition of Vivani Medical Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2578952152","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578952152?lang=en_us&edition=fundamental","pubTime":"2025-10-28 21:00","pubTimestamp":1761656458,"startTime":"0","endTime":"0","summary":"Gregg Williams, a Director and 10% Owner, reported the acquisition of common shares of Vivani Medical Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDLbGS0s9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner Gregg Williams Reports Acquisition of Vivani Medical Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2578934634","title":"Vivani Medical Raises $15.7 Million in Stock Offering and Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2578934634","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578934634?lang=en_us&edition=fundamental","pubTime":"2025-10-28 18:05","pubTimestamp":1761645912,"startTime":"0","endTime":"0","summary":"Vivani Medical Inc. has announced the pricing of a registered direct offering and a concurrent private placement, raising approximately $15.7 million in gross proceeds. The company will issue 6,000,000 shares of its common stock in the registered direct offering at $1.62 per share, and 3,703,703 shares in a private placement at the same price, purchased by Gregg Williams, the Chairman of Vivani's board. The net proceeds are intended to fund ongoing research and clinical development of the company's product candidates, as well as for working capital and general corporate purposes. ThinkEquity is acting as the sole placement agent for the registered direct offering.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. publi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL3gcGCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"1110749067","title":"Vivani Medical Completes $16 Million Fundraising","url":"https://stock-news.laohu8.com/highlight/detail?id=1110749067","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110749067?lang=en_us&edition=fundamental","pubTime":"2025-10-27 22:50","pubTimestamp":1761576621,"startTime":"0","endTime":"0","summary":"During early Monday trading, shares of biopharmaceutical firm Vivani Medical, Inc. (VANI) fell 5.9% after the company announced the completion of a $16 million fundraising at $1.62 per share. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SINA","VANI","BK4082"],"gpt_icon":0},{"id":"2578630286","title":"BRIEF-Vivani Medical Inc Prices 6,000,000 Shares At $1.62 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2578630286","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578630286?lang=en_us&edition=fundamental","pubTime":"2025-10-27 07:16","pubTimestamp":1761520567,"startTime":"0","endTime":"0","summary":"BRIEF-Vivani Medical Inc Prices 6,000,000 Shares At $1.62 EachOct 26 (Reuters) - Vivani Medical Inc VANI.O:VIVANI MEDICAL, INC. ANNOUNCES PRICING OF COMMON STOCK OFFERINGVIVANI MEDICAL INC - PRICES 6,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251026:nTUA22Y90Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2578665346","title":"Vivani Medical, Inc. Announces Pricing of Common Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2578665346","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578665346?lang=en_us&edition=fundamental","pubTime":"2025-10-27 07:15","pubTimestamp":1761520500,"startTime":"0","endTime":"0","summary":"ALAMEDA, Calif., Oct.  26, 2025  (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/26/3174279/0/en/Vivani-Medical-Inc-Announces-Pricing-of-Common-Stock-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082","CRGT"],"gpt_icon":0},{"id":"2577831360","title":"Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2577831360","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577831360?lang=en_us&edition=fundamental","pubTime":"2025-10-22 20:30","pubTimestamp":1761136200,"startTime":"0","endTime":"0","summary":"ALAMEDA, Calif., Oct.  22, 2025  (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/22/3171115/0/en/Vivani-Medical-to-Present-at-the-ThinkEquity-Conference-on-October-30-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRGT","VANI","BK4082"],"gpt_icon":0},{"id":"2575741130","title":"Director and 10% Owner Gregg Williams Reports Acquisition of Vivani Medical Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2575741130","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575741130?lang=en_us&edition=fundamental","pubTime":"2025-10-16 21:14","pubTimestamp":1760620441,"startTime":"0","endTime":"0","summary":"Gregg Williams, a Director and 10% Owner of Vivani Medical Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 16, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL4N1HbW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner Gregg Williams Reports Acquisition of Vivani Medical Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2573998933","title":"Vivani Medical Unveils Investor Presentation Highlighting Innovative Long-Acting GLP-1 Implant for Obesity Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2573998933","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573998933?lang=en_us&edition=fundamental","pubTime":"2025-10-07 05:55","pubTimestamp":1759787719,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief on October 06, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL9FNwwP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivani.com","stockEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.1176},{"period":"3month","weight":0.1157},{"period":"6month","weight":0.1739},{"period":"1year","weight":0.0385},{"period":"ytd","weight":0.1638}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.026838},{"month":2,"riseRate":0.363636,"avgChangeRate":0.296945},{"month":3,"riseRate":0.363636,"avgChangeRate":0.204883},{"month":4,"riseRate":0.363636,"avgChangeRate":0.003835},{"month":5,"riseRate":0.545455,"avgChangeRate":0.046981},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.05177},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.022536},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.10962},{"month":9,"riseRate":0.636364,"avgChangeRate":-0.039438},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.074632},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.062683},{"month":12,"riseRate":0.333333,"avgChangeRate":0.018949}],"exchange":"NASDAQ","name":"Vivani Medical, Inc.","nameEN":"Vivani Medical, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vivani Medical, Inc.(VANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vivani Medical, Inc.,VANI,Vivani Medical, Inc.股票,Vivani Medical, Inc.股票老虎,Vivani Medical, Inc.股票老虎国际,Vivani Medical, Inc.行情,Vivani Medical, Inc.股票行情,Vivani Medical, Inc.股价,Vivani Medical, Inc.股市,Vivani Medical, Inc.股票价格,Vivani Medical, Inc.股票交易,Vivani Medical, Inc.股票购买,Vivani Medical, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vivani Medical, Inc.(VANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction